Persistent paralysis in critically ill patients after long-term administration of vecuronium
about
Neuromuscular blocking agents for patients with acute respiratory distress syndromeNeuromuscular blocking agents for patients with acute respiratory distress syndromeCombination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromesICU-acquired weakness: what is preventing its rehabilitation in critically ill patients?Comparison of train-of-four and best clinical assessment during continuous paralysisAcute quadriplegic myopathy in a 17-month-old boyPharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patientsNarrative review: ventilator-induced respiratory muscle weakness.Electrophysiology of neuromuscular disorders in critical illness.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspectsIntensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockSevere withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion.A ventilator strategy combining low tidal volume ventilation, recruitment maneuvers, and high positive end-expiratory pressure does not increase sedative, opioid, or neuromuscular blocker use in adults with acute respiratory distress syndrome and maDisorders of the respiratory muscles.Acquired neuromuscular disorders in the intensive care unit.Acute quadriplegia caused by necrotizing myopathy in a renal transplant recipient with severe pneumonia: acute onset and complete recovery.A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome.The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsisSustained Neuromuscular Blockade after Vecuronium Use in a Premature Infant.Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort studyBrief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy.Functional Status in ICU Survivors and Out of Hospital Outcomes: A Cohort StudyContinuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients.Sedation and analgesia in the mechanically ventilated patient.Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence?Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.Neuromuscular complications of sepsis in children.Prolonged paralysis after neuromuscular blockade.Recent advances in critical care.Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.Pharmacokinetics and pharmacodynamics in the critically ill patient.Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unit.Neurological complications of severe illness and prolonged mechanical ventilation.Muscle weakness after administration of neuromuscular blocking agents: do not immobilize the diaphragm unnecessarily.The cardiovascular implications of sedatives in the cardiac intensive care unit.[Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].
P2860
Q24186094-ECD2E498-408F-466C-9961-E063795E56ABQ24201385-BDC0A884-E693-4CF3-BB1D-DF9C88828B89Q24800821-2669812A-7121-433E-B702-50ADD6B9DD7AQ26861446-52338339-F49E-437F-909C-9FA4BB3D933CQ28254873-360617F0-5EF3-4CBC-BF72-22B3365ED5B4Q28368975-0F916092-7FD5-4F82-BE1E-905215A96C07Q31805898-CB558A0F-15F3-4191-A5B4-0F508937D2DBQ33236613-80C9A1CA-7DEC-42B0-81A1-AC18332E87F4Q33799376-368EE86F-D70A-49A7-9228-184392753B0FQ34076538-A1FC7D1D-C928-4628-86BF-877720DE9CBAQ34326509-2ADA91DC-3AB7-4450-9658-D7D4C302F7B6Q34483183-972F36DB-7B65-4514-A4D7-F1A27A56B522Q34517838-A3628145-C0CA-4FDB-9701-4CB2BB63FF1EQ34697264-267393DE-BAB8-46EC-A245-EC935C1D4095Q34732494-E8868225-C08A-4C82-9C26-5AC707B02A38Q34756121-30B1D756-EAE7-4C56-8D0C-EF5CC6EDE5B0Q35162640-266756CD-71D7-45A1-818B-F179A998F768Q35548943-31AE945D-966D-4C43-9E08-839443E606F2Q35652095-51B67932-521E-48B3-8903-99FE0FDD2441Q35809472-EA91005C-7C8D-475A-BC50-920D284A1272Q36111211-B612D7E2-A8AC-4C29-8BA9-49A86028889FQ36156547-C25639F3-3CA5-4A20-A0CC-43CD7EB2F027Q36322710-0F3C40A6-5470-4BE2-9268-25B9EEA7AB47Q36641905-7ECCF218-98B6-4C0D-BE66-700BDFB95CFFQ36803538-8748BE27-49C0-4A1E-BC70-41D47A982ADAQ37396332-D46D8C81-CEA8-4B99-8D51-8CC946006F50Q37948029-0DF69015-967B-4A34-8E32-31BDA7DF19CBQ38006921-E94B5861-1B44-40E8-90D7-B6132DC44ED7Q38107537-8A8EF3C0-8589-4922-8C69-383DD1D3EE82Q38225008-12EAD997-55F3-4797-ADE0-662B6831957EQ40382456-8BF6206B-A702-47A7-987D-42229AF5583AQ40468774-C918C76B-6D90-4F82-9DC0-E4C1C958FBA3Q40748102-2268CED1-ABE9-4B2F-A360-01DF1BA6C41FQ40801223-F5F9928A-7FCD-46FA-A409-66939A91D076Q40815584-A2E4AB7B-7F46-489E-920E-9830F6D67228Q41134681-D5F88B28-D73D-4A1C-9CD9-9B2669CAFDEDQ41163259-873B204A-3027-4752-A8DD-B2CC3934A06BQ42874773-9B24D04A-55F7-4502-A7D9-7C5F11B74A50Q43075698-E9708D2D-FC1E-4819-BE0A-BCCFF4FF1196Q44967218-99C89783-6235-41EA-A227-A1B7B83AC610
P2860
Persistent paralysis in critically ill patients after long-term administration of vecuronium
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Persistent paralysis in critic ...... m administration of vecuronium
@ast
Persistent paralysis in critic ...... m administration of vecuronium
@en
Persistent paralysis in critic ...... m administration of vecuronium
@nl
type
label
Persistent paralysis in critic ...... m administration of vecuronium
@ast
Persistent paralysis in critic ...... m administration of vecuronium
@en
Persistent paralysis in critic ...... m administration of vecuronium
@nl
prefLabel
Persistent paralysis in critic ...... m administration of vecuronium
@ast
Persistent paralysis in critic ...... m administration of vecuronium
@en
Persistent paralysis in critic ...... m administration of vecuronium
@nl
P2093
P1476
Persistent paralysis in critic ...... m administration of vecuronium
@en
P2093
J E Caldwell
L D Gruenke
M A Matthay
M L Sharma
R D Miller
P356
10.1056/NEJM199208203270804
P407
P577
1992-08-20T00:00:00Z